Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart BDR | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$4.34T | 37.5x | 0.95 | R$33.70 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger Co | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$242.18B | 19.3x | 0.73 | R$365.57 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$213.44B | 21.6x | -5.12 | R$220 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano DRC | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$152.79B | 30.9x | -1.24 | R$462.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RAIADROGASIL ON | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$29.72B | 23.5x | 1.23 | R$17.35 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
Grupo Mateus | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$16.36B | 10.6x | 0.97 | R$7.28 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$14.16B | 14.8x | 0.4 | R$10.50 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.8% Upside | Upgrade to Pro+ | |
Pague Menos | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$2.34B | 37.5x | -0.84 | R$3.83 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.5% Upside | Upgrade to Pro+ | |
Brasileira De Dist | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.91B | -1.5x | -0.03 | R$3.90 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -23.1% Downside | Upgrade to Pro+ | |
Dimed | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.47B | 13x | 0.47 | R$9.84 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
D1000 On | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$225.69M | 12x | -0.45 | R$4.46 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |